Therapy of Angiosarcoma with Thalidomide and Lenalidomide
Angiosarcoma is an uncommon malignancy with a poor prognosis. Systemic therapy options for patients with metastatic disease generally have limited effectiveness. In this case study, a 73-year-old male with metastatic angiosarcoma who previously declined chemotherapy and developed progressive disease after checkpoint inhibitor immunotherapy elected to try thalidomide based on 6 case reports describing its effectiveness. Thalidomide resulted in stable disease for 9 months, but due to severe neuropathy as a side effect, lenalidomide was then substituted for thalidomide. The patient continued to have stable disease on lenalidomide for an additional 16 months and ongoing. This is the first case study to report on effective treatment of angiosarcoma with lenalidomide. Further investigation of lenalidomide in the management of angiosarcoma is warranted.
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Therapy of Angiosarcoma with Thalidomide and Lenalidomide ; volume:14 ; number:3 ; year:2021 ; pages:1580-1585 ; extent:6
Case reports in oncology ; 14, Heft 3 (2021), 1580-1585 (gesamt 6)
- Urheber
-
Mattes, M. Jules
Mattes, Jeffrey A.
Groisberg, Roman
Mattes, Malcolm D.
- DOI
-
10.1159/000519970
- URN
-
urn:nbn:de:101:1-2022011223343340280797
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:19 MESZ
Datenpartner
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mattes, M. Jules
- Mattes, Jeffrey A.
- Groisberg, Roman
- Mattes, Malcolm D.
Ähnliche Objekte (12)
Surgical therapy of primary hepatic angiosarcoma
Radical Radiation Therapy for Radiation-Induced Angiosarcoma with Local Control
Treatment of patients with multiple myeloma progressing on frontline-therapy with lenalidomide
Angiosarcoma treated successfully with anti-PD-1 therapy - a case report
Cutaneous Angiosarcoma
ANGIOSARCOMA OF SPINE
The clinical management of lenalidomide-based therapy in patients with newly diagnosed multiple myeloma
The clinical management of lenalidomide-based therapy in patients with newly diagnosed multiple myeloma
Bortezomib-induced hyponatremia: tolvaptan therapy permits continuation of lenalidomide, bortezomib and dexamethasone therapy in relapsed myeloma
Clinical Pharmacokinetics and Pharmacodynamics of Lenalidomide
Angiosarcoma of the scalp
Angiosarcoma of the scalp
Surgical therapy of primary hepatic angiosarcoma
Radical Radiation Therapy for Radiation-Induced Angiosarcoma with Local Control
Treatment of patients with multiple myeloma progressing on frontline-therapy with lenalidomide
Angiosarcoma treated successfully with anti-PD-1 therapy - a case report
Cutaneous Angiosarcoma
ANGIOSARCOMA OF SPINE
The clinical management of lenalidomide-based therapy in patients with newly diagnosed multiple myeloma
The clinical management of lenalidomide-based therapy in patients with newly diagnosed multiple myeloma
Bortezomib-induced hyponatremia: tolvaptan therapy permits continuation of lenalidomide, bortezomib and dexamethasone therapy in relapsed myeloma
Clinical Pharmacokinetics and Pharmacodynamics of Lenalidomide
Angiosarcoma of the scalp
Angiosarcoma of the scalp
Surgical therapy of primary hepatic angiosarcoma
Radical Radiation Therapy for Radiation-Induced Angiosarcoma with Local Control
Treatment of patients with multiple myeloma progressing on frontline-therapy with lenalidomide
Angiosarcoma treated successfully with anti-PD-1 therapy - a case report
Cutaneous Angiosarcoma
ANGIOSARCOMA OF SPINE
The clinical management of lenalidomide-based therapy in patients with newly diagnosed multiple myeloma
The clinical management of lenalidomide-based therapy in patients with newly diagnosed multiple myeloma
Bortezomib-induced hyponatremia: tolvaptan therapy permits continuation of lenalidomide, bortezomib and dexamethasone therapy in relapsed myeloma
Clinical Pharmacokinetics and Pharmacodynamics of Lenalidomide
Angiosarcoma of the scalp